Ore Pharmaceutical (GLGC) Inactive 10-Q2006 Q1 Quarterly report

Filed: 10 May 06, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: accelerated, activity, Add, aggregate, attributable, authorized, bad, behalf, book, check, closing, Committee, Confidential, cover, decide, diluted, directly, discretion, division, duly, earlier, Emerging, emphasize, Employer, established, evidenced, exhibit, facilitate, FAS, FASB, FDA, February, filer, forfeiture, found, FSP, funding, Identification, increasingly, indirectly, instance, integrated, interpretation, Jr, lieu, list, lost, mark, mechanism, MetriGenix, milestone, model, multiplied, mutual, mutually, notice, November, optimal, Organon, original, ownership, par, partner, payroll, personnel, Pfizer, Phase, Philip, pipeline, preceding, proposed, provision, public, registrant, replace, repricing, requested, requisite, restricted, retention, Roche, Rohrer, RSM, salary, scheduled, seek, seeking, separate, separately, shell, shorter, size, stockholder, structure, subset, summary, Task, thereunto, top, ToxEdge, trading, transition, transitioned, treatment, undersigned, underway, variability, variable, vary, varying, warrant, Washington

Removed: acquiring, added, adding, Additionally, amortization, amortized, analyzed, approved, bear, began, budget, commercially, compensatory, complementary, comply, conform, efficient, end, extension, GeneChip, history, improvement, industry, larger, Liquidity, manner, modest, offered, realized, reduce, reference, refund, restate, retain, retrospective, shown, site, tax, trademark, transaction, treaty, twelve, withholding

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

GLGC similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Each of the undersigned hereby certifies, in his capacity as an officer of Gene Logic Inc. (the “Company”), for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

	·	The Quarterly Report of the Company on Form 10-Q for the quarterly period ended March 31, 2006 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
	·	The information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company.




Date: May 10, 2006	By:	/s/ Mark D. Gessler
		Mark D. Gessler
		Chief Executive Officer




Date: May 10, 2006	By:	/s/ Philip L. Rohrer, Jr.
		Philip L. Rohrer, Jr.
		Chief Financial Officer